Platform

AI-Moderated Healthcare Research Platform with Verified Clinician Panel

AI moderator runs voice and video interviews with license + NPI verified nurses, NPs, physicians, and specialists. BAA on every engagement, HIPAA Safe Harbor de-identification by default, and a monthly subscription with 50 interviews included — fielding starts the same week the brief is locked.

BAA on every healthcare engagement
Monthly subscription with 50 interviews included
0.4% verified AI-respondent leak rate
Verified clinician on a Carevoices research interview
Live
carevoices.health/dashboard
Study Dashboard 3 Active
0
Depth Levels
▲ 2.1%
0
Panelists
▲ 3.5%
0
Delivery
▼ 1.2%
Response Trend 7 days
Choose study type
Buying Process
Message Validation
Concept Testing
Advisory
Tracker
Workforce
48-72hrs Delivery ▲ 2.1%
78% Complete
Live

Trusted by teams at

Nivella Health
What It Is

What Is the Carevoices Platform?

Carevoices is an AI-moderated qualitative research platform purpose-built for healthcare. The AI moderator runs voice and video interviews with verified clinicians from a panel of 10k+ healthcare practitioners. Every engagement includes a BAA, HIPAA Safe Harbor de-identified transcripts, US data residency, and Sunshine Act-ready data handling — bundled into a monthly subscription with 50 interviews included.

The platform is structured around eight value propositions: compliance built in (BAA on every engagement, HIPAA Safe Harbor de-identification, US data residency, Sunshine Act / Open Payments handling); faster insights (full studies delivered in under 2 weeks); deeper insights (voice moderation trained on research methods that get participants to open up); always-on listening as a competitive advantage rather than point-in-time studies; flexible recruitment (bring your own panel, or use Carevoices' panel of 10k+ verified healthcare practitioners); multi-lingual reach across 50+ languages; multi-modal delivery via text, voice, or video; and qual at scale — run 1,000s of interviews to gain confidence for million-dollar decisions.

Every panelist is license + NPI verified at intake, with NPPES Registry cross-check, state board verification, and behavioral fingerprinting built across interviews. The 6-Layer Fraud Detection Stack — including the AI-on-AI Detection Layer — measured a 0.4% verified AI-respondent leak rate in Q3 2025, vs. 18-31% on benchmarked legacy panels.

The monthly subscription bundles recruitment, AI moderation, transcription, HIPAA Safe Harbor de-identification, BAA, US data residency, Sunshine Act handling, and standard-format delivery — 50 interviews per month included, additional interviews available at the standard credit rate. Buying-process studies, message validation, concept testing, advisory boards, tracker waves, and KOL deep-dives all run within the same subscription. Customers use their own analysis stack — internal data scientists, MarketSight, Forsta, Claude Enterprise — on the de-identified transcripts the platform delivers.

The Problem

Why Generic AI Research Tools Fail Healthcare

Most AI research tools were built for consumer brands. They can't sign a BAA. They don't have a verified clinician panel. They weren't designed to handle PHI safely. Healthcare buyers have been forced to choose between AI-native speed and regulatory rigor.

1

No BAA = Disqualified

Pharma compliance, hospital procurement, and medtech legal all require Business Associate Agreements before any vendor touches PHI. Generic AI research tools either can't sign one or take 90 days to add the capability — both kill the engagement.

2

Specialty Recruiting Takes Weeks

Finding 25 GI oncology specialists, 50 OR nurses, or 30 cardiologists is the bottleneck on every custom study. Most vendors quote 6-10 weeks for fielding alone, before analysis even begins.

3

Compliance Treated as Bolt-On, Not Architecture

AI research tools claim BAA capability without infrastructure to back it up. When your compliance team digs in, the vendor either backs off or asks for a 90-day delay. Both kill the engagement before fielding starts.

4

Identifier Stripping Is Manual or Missing

Most legacy vendors treat de-identification as a post-fielding service charge. Generic AI tools skip it entirely. Healthcare buyers need HIPAA Safe Harbor de-identification built into the delivery pipeline by default.

Results

What Teams Value Most

What matters most to teams after switching to AI-moderated research.

Healthcare engagements covered by BAA
100%

BAA on every engagement (template available pre-signature). HIPAA Safe Harbor de-identification by default. US data residency, AWS / GCP US regions only. PHI never trains a model.

Fielding starts the week the brief is locked
Same week

Monthly subscription with 50 interviews included means fielding starts the same week — no per-project procurement cycle. Always-on listening capability vs. project-by-project commissioning at incumbent vendors.

Verified AI-respondent leak rate
0.4%

PNAS 2025 research shows AI bots evade legacy fraud detection 99.8% of the time. The 6-Layer Fraud Detection Stack — including the AI-on-AI Detection Layer — measured 0.4% leak rate in Q3 2025 versus 18-31% on benchmarked legacy panels.

Verified healthcare practitioners on the panel
10k+

License + NPI verified at intake. NPPES Registry cross-check, state board verification, specialty + practice setting profiled. Behavioral fingerprinting across interviews. Or bring your own panel — flexible recruitment is built in.

Process

How It Works

From research question to evidence-backed intelligence in four steps.

1
Day 1

Brief us

Tell us your study question and audience. Our research agent translates into a structured learning plan with objectives, key questions, and conversation flow. You review and edit before fielding starts.

2
Days 2-15

We recruit and moderate

The AI moderator runs voice or video interviews with verified clinicians from the panel. License + NPI verification, behavioral fingerprinting, AI-on-AI fraud detection — all built in. Monthly subscription includes 50 interviews; additional interviews at standard credit rate.

3
Days 16-18

We de-identify and deliver

Transcripts and recordings stripped of identifiers using HIPAA Safe Harbor methodology, then delivered to your team in standard formats your existing analysis stack already accepts.

4
Ongoing

You analyze and re-engage

Use whatever you already use — internal team, MarketSight, Forsta, Claude Enterprise, internal Snowflake. Always-on listening means the next study fields the moment the prior one closes.

Capabilities

What the Platform Includes

Compliance Built In

BAA on every engagement, HIPAA Safe Harbor de-identification, US data residency, Sunshine Act / Open Payments handling — all bundled into the engagement, never invoiced as a separate line item.

4-Layer Compliance Stack as architecture, not retrofit

Faster Insights

Fielding starts the same week the brief is locked. Full studies delivered in under 2 weeks. No per-project procurement cycle, no scoping renegotiation between projects.

Under 2 weeks per study, same-week fielding

Deeper Insights

Voice moderation trained on research methods that get participants to open up. Structured laddering surfaces drivers, motivations, and emotional context that surveys can't reach.

Equivalent depth to human-moderated qualitative

Always-On Listening

Monthly subscription with 50 interviews included means continuous voice-of-customer rather than point-in-time projects. Run multiple study types within the same engagement.

Continuous capability, not episodic commissioning

Flexible Recruitment

Bring your own panel — your existing nurse staff, hospital workforce, KOL relationships — or use the panel of 10k+ verified healthcare practitioners. License + NPI verified at intake.

Your panel, ours, or both in one study

Multi-Lingual

Native-language AI moderation across 50+ languages. International HCP research, cross-border patient studies, multi-market trackers — without losing depth in translation.

50+ languages, native moderation

Multi-Modal Delivery

Participants choose what's natural — text, voice, or video. Same-day session for the busy specialist; deeper voice interview for the engaged nurse; video for stimuli reactions. Meet participants where they are.

Three modalities, one engagement

Qual at Scale

Run 1,000s of interviews to gain confidence for million-dollar decisions. AI moderation eliminates the linear-cost trap that limits traditional qualitative to 25-50 interviews per study.

1,000+ interviews per engagement is normal
Methodology & Trust

Healthcare-Vertical Compliance as Architecture, Not Retrofit

Generic AI research tools and consumer-grade research platforms can be retrofit for healthcare engagements — but the retrofit shows. Carevoices is built around healthcare compliance from day one. Here's how the architecture compares.

Carevoices Architecture

  • BAA on every engagement, template available pre-signature
  • HIPAA Safe Harbor de-identification built into delivery pipeline
  • US data residency confirmed in writing per contract
  • Sunshine Act / Open Payments handling — NPI capture + CMS-format export
  • License + NPI verified clinician panel (NPPES Registry cross-check at intake)
  • 6-Layer Fraud Detection Stack — including AI-on-AI Detection Layer
  • Stimuli pre-approval workflow with versioning and audit trail
  • PHI never trains a model — period

What Generic AI Research Tools Require

  • BAA execution often unavailable or 60-120+ day legal retrofit
  • De-identification typically a post-fielding service charge or skipped entirely
  • US data residency unspecified or non-default; review per engagement
  • Sunshine Act handling not built; bolt-on per engagement
  • Self-identified panel without license verification or NPI cross-check
  • Legacy fraud detection that PNAS 2025 shows AI bots evade 99.8% of the time
  • No native stimuli pre-approval workflow for FDA-relevant content
  • PHI in model training pipeline unless explicitly contracted otherwise

In progress: SOC 2 Type II audit (in evidence-collection phase). Letter of audit attestation available on request to qualified prospects under NDA. HITRUST CSF and ISO 27001 are 2026-2027 roadmap.

FAQs

Frequently Asked Questions

Carevoices is an AI-moderated qualitative research platform purpose-built for healthcare. The AI moderator runs voice and video interviews with license + NPI verified clinicians from a panel of 10k+ healthcare practitioners. Every engagement includes a BAA, HIPAA Safe Harbor de-identified transcripts, US data residency, and Sunshine Act-ready data handling — bundled into a monthly subscription with 50 interviews included.
Yes. BAA execution is standard on every healthcare engagement. The template is available pre-signature on request, and custom terms are accommodated when your legal team needs them. Most BAAs execute within 5-10 business days.
Carevoices is healthcare-vertical-first. License + NPI verified clinician panel, BAA on every engagement, HIPAA Safe Harbor de-identification by default, US data residency confirmed in writing, Sunshine Act handling built in. Generic AI research tools were built for consumer brands and require 60-120+ day compliance retrofit per engagement — most pharma, medtech, and hospital procurement teams disqualify them at the BAA gate.
50 interviews per month, recruitment from the verified clinician panel (or your own panel), AI-moderated voice/video moderation, transcription, HIPAA Safe Harbor de-identification, BAA, US data residency, Sunshine Act handling, and delivery to your analysis stack. Buying-process studies, message validation, concept testing, advisory boards, tracker waves, and KOL deep-dives all run within the same subscription. Additional interviews above 50/month are available at the standard credit rate.
Fielding starts the same week the brief is locked. The monthly subscription means there's no per-project procurement cycle — once you're a Carevoices customer, the next study fields the moment the prior one closes. Most studies deliver de-identified transcripts within 2 weeks of brief lock.
Yes. Bring your own panel — existing nurse staff, hospital workforce, KOL relationships — or use Carevoices' panel of 10k+ verified healthcare practitioners. The platform handles both sources within a single engagement, and the 6-Layer Fraud Detection Stack runs across both regardless of source.
PNAS 2025 research shows AI bots evade legacy fraud detection 99.8% of the time. Our Q3 2025 Panel Fraud Transparency Report (1,108 audited transcripts) measured 18-31% AI-respondent leak rates on benchmarked legacy panels. Carevoices' 6-Layer Fraud Detection Stack — including the AI-on-AI Detection Layer — measured 0.4% leak rate in the same audit period. For healthcare research informing FDA submissions or hospital workforce decisions, the verification gap is material.
Native-language AI moderation across 50+ languages. International HCP research, cross-border patient studies, multi-market trackers run without losing depth in translation. De-identified transcripts are delivered in source language plus English translation for analysis stack compatibility.
No. PHI never trains a model — period. HIPAA Safe Harbor de-identification is applied to every transcript before delivery. Data stays in US AWS and GCP regions, confirmed in writing in every contract. Sub-processors operate under no-training contracts.
NPI capture at panelist intake. Honoraria payments tracked per panelist with CMS-format export ready. Sponsors using Carevoices for HCP research can pull Sunshine Act / Open Payments-ready reports directly from the engagement. Built into the architecture, not bolted on.
Get Started

See How the Platform Works for Your Team

Book a demo to walk through the platform, see a sample compliant deliverable, and discuss how the monthly subscription fits your research backlog.

30-min with founder

Walkthrough of a sample compliant deliverable and how the monthly subscription fits your research backlog.

BAA, HIPAA, residency

How the 4-Layer Compliance Stack clears procurement at top-20 pharma, hospital systems, and medtech legal.

Most engagements clear procurement within 30-60 days at top-20 pharma, hospital systems, and medtech.